USPH Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
222.6M
+4.0%
214.1M
+8.0%
198.3M
-2.2%
202.7M
+2.8%
197.1M
Cost of Revenue
179.5M
0
0
+100.0%
-468703000
-392.5%
160.3M
Gross Profit
43.0M
-79.9%
214.1M
+8.0%
198.3M
-70.5%
671.4M
+1721.0%
36.9M
Operating Expenses
17.9M
-90.7%
192.1M
+3.4%
185.8M
-71.6%
654.7M
+5572.0%
11.5M
R&D
0
0
0
0
0
SG&A
17.8M
-87.7%
144.4M
+4.8%
137.8M
-71.3%
480.0M
+2656.5%
17.4M
Operating Income
25.1M
+14.4%
21.9M
+75.8%
12.5M
-25.6%
16.8M
-33.8%
25.3M
EBITDA
31.3M
+12.4%
27.9M
+50.9%
18.5M
-13.6%
21.4M
-31.3%
31.2M
Net Income
17.6M
+18.0%
14.9M
+82.7%
8.2M
-11.1%
9.2M
-48.0%
17.6M
EPS (Basic)
$-1.04
-516.0%
$0.25
+308.3%
$-0.12
+72.1%
$-0.43
-189.6%
$0.48
EPS (Diluted)
$-1.04
-516.0%
$0.25
+308.3%
$-0.12
+72.1%
$-0.43
-189.6%
$0.48
Shares (Diluted)
14.9M
-0.9%
15.1M
-0.6%
15.2M
+0.0%
15.2M
-0.2%
15.2M
US Physical Therapy (USPH) — Financials